|Bid||3.0000 x 1800|
|Ask||3.0200 x 4000|
|Day's Range||2.9600 - 3.0900|
|52 Week Range||0.3500 - 5.5600|
|Beta (5Y Monthly)||0.48|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Both Clover Health Investments (NASDAQ: CLOV) and Senseonics Holdings (NYSEMKT: SENS) have emerged as meme stocks over the last few months. Senseonics has been the much bigger winner so far, but that doesn't necessarily mean it will continue to outperform Clover Health going forward. In this Motley Fool Live video recorded on July 7, Motley Fool contributors Keith Speights and Brian Orelli discuss which of these two meme stocks is the better pick right now.
Shares of Senseonics Holdings (NYSEMKT: SENS) skyrocketed 340% in the first half of 2021. One key early catalyst for Senseonics was a positive coverage decision in January by health insurer EmblemHealth for the Eversense continuous glucose-monitoring (CGM) system used by individuals with diabetes. In June, Senseonics reported positive results from a clinical study of its version of the Eversense device that can remain implanted for 180 days.
Senseonics Holdings (NYSEAMERICAN:SENS) has been on a hot streak the past month. After going sideways for three months, SENS stock took off at the beginning of June. As I write this, it’s up more than 72% over the past 30 days. Source: Shutterstock If it keeps up this pace, it could be out of penny-stock status in no time. In my last article about the maker of glucose-monitoring products at the end of April, I honed in on the company’s accumulated deficit as a red flag for risk-averse investors.